Hasil Pencarian - Yu‐Yun Shao

Perbaiki Hasil
  1. 1
    Treatment outcome comparisons of first‐line targeted therapy in patients with KRAS wild‐type metastatic colorectal cancer: A nationwide database study

    Treatment outcome comparisons of first‐line targeted therapy in patients with KRAS wild‐type metastatic colorectal cancer: A nationwide database study oleh Yi‐Hsin Liang, Kuo‐Hsing Chen, Yu‐Yun Shao

    Diterbitkan 2023-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade

    It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade oleh Tsung-Hao Liu, Yu-Yun Shao, Chih-Hung Hsu

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma

    Reply to letter to the editor: Low skeletal muscle mass are predictive factors of survival for advanced hepatocellular carcinoma oleh Chih-Horng Wu, Yu-Yun Shao, Tiffany Ting-Fang Shih

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases

    Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases oleh Yu-Yun Shao, Ming-Chih Ho, Ann-Lii Cheng, Chih-Hung Hsu

    Diterbitkan 2014-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma

    Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinoma oleh Jan-Mou Lee, Yi-Ping Hung, Yi-Ping Hung, Kai-Yuan Chou, Cheng-Yun Lee, Shian-Ren Lin, Ya-Han Tsai, Wan-Yu Lai, Yu-Yun Shao, Yu-Yun Shao, Yu-Yun Shao, Chiun Hsu, Chiun Hsu, Chih-Hung Hsu, Chih-Hung Hsu, Yee Chao, Yee Chao

    Diterbitkan 2022-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma

    Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma oleh Ching-Tso Chen, Tsung-Hao Liu, Yu-Yun Shao, Kao-Lang Liu, Po-Chin Liang, Zhong-Zhe Lin

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions

    Characteristics and Risk Factors of Oxaliplatin-related Hypersensitivity Reactions oleh Yu-Yun Shao, Fu-Chang Hu, Jin-Tung Liang, Wen-Tzu Chiu, Ann-Lii Cheng, Chih-Hsin Yang

    Diterbitkan 2010-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan

    Impact of expanded strong opioid availability on opioid prescription patterns in patients with cancer: A population-wide cohort study in Taiwan oleh Tsung-Che Wu, Chih-Hung Hsu, Wei-Zen Sun, Ho-Min Chen, Chih-Peng Lin, Yu-Yun Shao

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases

    Modern Prospection for Hepatic Arterial Infusion Chemotherapy in Malignancies with Liver Metastases oleh Yi-Hsin Liang, Yu-Yun Shao, Jia-Yi Chen, Po-Chin Liang, Ann-Lii Cheng, Zhong-Zhe Lin

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma

    The unique characteristic in peripheral immune cells in patients with advanced hepatocellular carcinoma oleh Yi-Ping Hung, Yu-Yun Shao, Chiun Hsu, Chih-Hung Hsu, Jan-Mou Lee, Muh-Hwa Yang, Yee Chao

    Diterbitkan 2021-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma

    Total skeletal, psoas and rectus abdominis muscle mass as prognostic factors for patients with advanced hepatocellular carcinoma oleh Chih-Horng Wu, Po-Chin Liang, Chih-Hung Hsu, Fang-Tsu Chang, Yu-Yun Shao, Tiffany Ting-Fang Shih

    Diterbitkan 2021-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study

    Anti-PD-1 combined sorafenib versus anti-PD-1 alone in the treatment of advanced hepatocellular cell carcinoma: a propensity score-matching study oleh San-Chi Chen, Yi-Hsiang Huang, Ming-Huang Chen, Yi-Ping Hung, Rheun-Chuan Lee, Yu-Yun Shao, Yee Chao

    Diterbitkan 2022-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma

    Cyclin dependent kinase 9 inhibition reduced programmed death-ligand 1 expression and improved treatment efficacy in hepatocellular carcinoma oleh Yu-Yun Shao, Min-Shu Hsieh, Yi-Hsuan Lee, Hung-Wei Hsu, Rita Robin Wo, Han-Yu Wang, Ann-Lii Cheng, Chih-Hung Hsu

    Diterbitkan 2024-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma

    Dynamic Contrast-Enhanced and Intravoxel Incoherent Motion MRI Biomarkers Are Correlated to Survival Outcome in Advanced Hepatocellular Carcinoma oleh Bang-Bin Chen, Yu-Yun Shao, Zhong-Zhe Lin, Chih-Hung Hsu, Ann-Lii Cheng, Chiun Hsu, Po-Chin Liang, Tiffany Ting-Fang Shih

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

    Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer oleh Jhe‐Cyuan Guo, Chia‐Lang Hsu, Min‐Shu Hsieh, Chia‐Chi Lin, Ta‐Chen Huang, Hung‐Yang Kuo, Yu‐Yun Shao, Chih‐Hung Hsu

    Diterbitkan 2023-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    <i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma

    <i>Eg5</i> as a Prognostic Biomarker and Potential Therapeutic Target for Hepatocellular Carcinoma oleh Yu-Yun Shao, Nai-Yun Sun, Yung-Ming Jeng, Yao-Ming Wu, Chiun Hsu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng, Zhong-Zhe Lin

    Diterbitkan 2021-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma

    Association of annexin A10 expression with poor prognosis of intrahepatic cholangiocarcinoma oleh Yu-Yun Shao, Hung-Yang Kuo, Yung-Ming Jeng, Yao-Ming Wu, Hsiu-Po Wang, Chiun Hsu, Chih-Hung Hsu, Hey-Chi Hsu, Ann-Lii Cheng, Zhong-Zhe Lin

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab: An Exploratory Analysis of the Phase III IMbrave150 Study

    Impact of Bevacizumab Being Skipped due to Adverse Events of Special Interest for Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus... oleh Masatoshi Kudo, Kaoru Tsuchiya, Yu-Yun Shao, Richard S. Finn, Peter R. Galle, Michel Ducreux, Ann-Lii Cheng, Tatsuya Yamashita, Hironori Koga, Ryosuke Take, Kyoko Yamada, Takashi Asakawa, Yuki Nakagawa, Masafumi Ikeda

    Diterbitkan 2023-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size.

    Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor size. oleh Zhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, Yu-Yun Shao, Yi-Chun Yeh, Raymond Nien-Chen Kuo, Chih-Hung Hsu, James Chih-Hsin Yang, Ann-Lii Cheng, Mei-Shu Lai

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety

    Bevacizumab and atezolizumab as first-line therapy for advanced hepatocellular carcinoma: A Taiwanese subgroup analysis on efficacy and safety oleh Yu-Yun Shao, Yin-Hsun Feng, Chia-Jui Yen, Tsai-Sheng Yang, Ying-Chun Shen, Yee Chao, Jen-Shi Chen, Ching-Yen Su, Wei-Jen Chen, Hwa-Lin Hsiang, Chih-Hung Hsu

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: